| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/08/2006 | US20060120974 Nicotine delivery systems |
| 06/08/2006 | DE102004057595A1 Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen Substituted pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | CA2589489A1 Method of providing fast relief to a user of a nicotine chewing gum |
| 06/08/2006 | CA2589343A1 Platelet-derived growth factor-responsive neural precursor cells and progeny thereof |
| 06/08/2006 | CA2589013A1 Method to prepare piper laetispicum c.dc. extract, the extract and the application thereof |
| 06/08/2006 | CA2588961A1 Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 06/08/2006 | CA2588868A1 Remedy for alzheimer's disease |
| 06/08/2006 | CA2588867A1 Substituted pyridone derivative |
| 06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | CA2588457A1 Triazole compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 06/08/2006 | CA2586111A1 Methods and fluorinated compositions for treating amyloid-related diseases |
| 06/08/2006 | CA2575924A1 Toxin compounds with enhanced membrane translocation characteristics |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666468A1 Crf antagonists and heterobicyclic compounds |
| 06/07/2006 | EP1666465A1 Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor |
| 06/07/2006 | EP1666464A1 Piperidine derivative having nmda receptor antagonistic activity |
| 06/07/2006 | EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system |
| 06/07/2006 | EP1666460A1 Preventive for cerebral stroke recurrence |
| 06/07/2006 | EP1666452A2 Compounds to treat Alzheimer's disease |
| 06/07/2006 | EP1666092A2 Drug combination comprising a fatty acid and a uridine compound. |
| 06/07/2006 | EP1666068A1 Remedy for eye diseases accompanied by optic nerve injuries |
| 06/07/2006 | EP1666067A1 Drug containing chymase inhibitor as the active ingredient |
| 06/07/2006 | EP1666066A1 Remedy for down syndrome |
| 06/07/2006 | EP1666061A1 Use of antibody |
| 06/07/2006 | EP1666053A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors |
| 06/07/2006 | EP1666052A1 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 06/07/2006 | EP1666051A2 Remedies |
| 06/07/2006 | EP1666047A1 Pharmaceutical compositions comprising nitric oxide-releasing pyrrolidones |
| 06/07/2006 | EP1666037A2 Compositions for stimulating neurite growth |
| 06/07/2006 | EP1666031A1 Composition containing nanoparticles containing water-soluble basic drug encapsulated therein |
| 06/07/2006 | EP1666030A1 Improved nicotine lozenge and therapeutic method for smoking cessation |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1664317A2 Method for obtaining precursor z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| 06/07/2006 | EP1664269A2 Alpha-keto carbonyl calpain inhibitors |
| 06/07/2006 | EP1664063A1 Substituted piperazines of azepines, oxazepines, and thiazepines |
| 06/07/2006 | EP1664050A2 Neuroprotective bicyclic compounds and pharmaceutical compositions containing them |
| 06/07/2006 | EP1664045A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors |
| 06/07/2006 | EP1664042A1 IMIDAZO 1,5-a PYRIDINE OR IMIDAZO 1,5-a PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS |
| 06/07/2006 | EP1664017A1 Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
| 06/07/2006 | EP1664012A1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
| 06/07/2006 | EP1664005A1 Thiazole derivatives as cannabinoid receptor modulators |
| 06/07/2006 | EP1663996A1 (thio)carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
| 06/07/2006 | EP1663994A1 Condensed pyrimidine compounds as inhibitors of voltage-gated ion channels |
| 06/07/2006 | EP1663983A1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 06/07/2006 | EP1663981A1 Piperazinyl-quinoline derivatives useful for the treatment of cns disorders |
| 06/07/2006 | EP1663980A1 Quinoline compounds and pharmaceutical compositions containing them |
| 06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
| 06/07/2006 | EP1663972A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders |
| 06/07/2006 | EP1663968A1 Process for the preparation of pure levetiracetam |
| 06/07/2006 | EP1663398A1 Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline reuptake inhibitors |
| 06/07/2006 | EP1663298A2 Use of proline specific endoproteases to hydrolyse peptides and proteins |
| 06/07/2006 | EP1663248A1 7-heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 06/07/2006 | EP1663246A2 Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 06/07/2006 | EP1663244A2 Pteridine derivatives for the treatment of septic shock and tnf-alpha-related diseases. |
| 06/07/2006 | EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 06/07/2006 | EP1663229A2 Pharmaceutical combinations of hydrocodone and naltrexone |
| 06/07/2006 | EP1663218A1 Use of gabaa receptor agonists for the treatment of hearing, vestibular and attention disorders, intention tremor and restless leg syndrome |
| 06/07/2006 | EP1663215A1 Novel medical use of selective cb1- receptor antagonists |
| 06/07/2006 | EP1663208A1 Use of telmisartan for the prevention of vascular headache |
| 06/07/2006 | EP1663205A1 Use of 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 06/07/2006 | EP1663203A1 Pharmaceutical compositions for the treatment of organophosphate poisoning |
| 06/07/2006 | EP1663199A1 Compositions and methods using same for treating amyloid-associated diseases |
| 06/07/2006 | EP1663159A2 Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation |
| 06/07/2006 | EP1662875A2 Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1434787A4 Lp mammalian proteins; related reagents |
| 06/07/2006 | EP1427723B1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 06/07/2006 | EP1423145B1 Compositions for the treatment of parkinson's disease containing a cb1 receptor antagonist and a product that activates dopaminergic neurotransmission in the brain |
| 06/07/2006 | EP1421075B1 Piperidine derivatives useful as ccr5 antagonists for the treatment of hiv |
| 06/07/2006 | EP1411899A4 Taste masking composition |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1373188B1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 06/07/2006 | EP1368047A4 Composition containing asiasari radix extracts for protecting brain cells and improving memory |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 06/07/2006 | EP1285654B1 Autonomic system controlling agents and health drinks and foods |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | EP1251860B1 Somnogenic activity of non-pathogenic lactic acid bacteria |
| 06/07/2006 | EP1147113B1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 06/07/2006 | EP1105419B1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 06/07/2006 | EP1102583B1 Treatment of addiction to nicotine and addiction-related behavior |
| 06/07/2006 | EP1038015B1 Mood disorder gene |
| 06/07/2006 | EP0929298B1 Pharmaceutical compositions comprising s-(-)-n-propargyl-1-amino indan |
| 06/07/2006 | CN1784409A Fused pyrimidine derivatives with CRF activity |
| 06/07/2006 | CN1784408A 8-substituted-6,7,8,9-tetrahy9dropyrimido (1,2-a) pyrimidin-4-one derivatives |
| 06/07/2006 | CN1784406A Purification and crystalline forms of zaleplon |
| 06/07/2006 | CN1784405A Microcrystal |
| 06/07/2006 | CN1784404A Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof |
| 06/07/2006 | CN1784392A Benzothiazole derivative compounds,compositions and uses |
| 06/07/2006 | CN1784241A Glutamate receptor antagonists as neuroprotectives |
| 06/07/2006 | CN1784240A Alzheimer's disease treatment method |
| 06/07/2006 | CN1784237A Freeze-dried preparation containing methylcobalamin and process for producing the same |
| 06/07/2006 | CN1784233A Combination of a glycine/NMDA antagonist and a tachykinin NK-1 receptor antagonist for use in the treatment of neurodegeneration |
| 06/07/2006 | CN1784230A Positive modulators of nicotinic acetylcholine receptors |
| 06/07/2006 | CN1784228A Novel compositions |
| 06/07/2006 | CN1784222A Therapeutic patch with polysiloxane matrix comprising capsaicin |